Viking Therapeutics Inc (VKTX) Company Profile & Statistics

Viking Therapeutics Inc
VKTX
(Nasdaq - US)
Closed
49.62
-3.95 (-7.37%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:50.31+0.69 (+1.39%)
Open
53.13
High
53.15
Low
49.00

About Viking Therapeutics Inc

CEO

Brian Lian

Headquarters

9920 pacific heights blvd, suite 350

san diego, ca 92121, united states

Auditor

Marcum LLP

Employees

Share Holders

Website

www.vikingtherapeutics.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA JOLLA, United States.

Viking Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	5.53B
Enterprise Value	5.49B
Enterprise Value/EBITDA (ttm)	-39.63
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.06
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-12.73%
Return on Invested Capital (ttm)	-15.14%
Return on Assets (ttm)	-12.31%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-138.41M
Net Income Avi to Common (ttm)	-96.75M
Diluted EPS (ttm)	-0.93

Share Statistics

Beta (5Y Monthly)	1.00
52-Week Change	321.58%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	110.80M
Dividend Yield	0.00%
Float ⁴	106.20M
% Held by Insiders	4.70%
% Held by Institutions	76.03%

Balance Sheet

Total Cash (mrq)	942.26M
Total Cash Per Share (mrq)	8.50
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	36.47%
Quick Ratio (mrq)	36.47%
Book Value Per Share (mrq)	8.18

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.51
Free Cash Flow (ytd)	-56.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Viking Therapeutics Inc

Trade With A Regulated Broker